TheFly.com
Open Search
keyboard_arrow_down
Type symbol to search
This symbol is non-existent:
List is empty.
Search
HCM
Hutchmed
$
()
HCM
Hutchmed announces closing of fruquintinib license to Takeda
HCM
,
TAK
3/14/2023 - 09:33am
Hutchmed completes patient enrollment for amdizalisib trial
HCM
2/27/2023 - 05:32am
Hutchmed licenses fruquintinib to Takeda Pharmaceutical for up to $1.13B
HCM
,
TAK
1/23/2023 - 05:07am
Hutchmed announces inclusion of ORPATHYS in China's NRDL
HCM
,
AZN
1/18/2023 - 09:36am
Hutchmed completes patient enrollment for ESLIM-01 trial
HCM
1/3/2023 - 05:19am
Hutchmed initiates filing of rolling submission of fruquintinib NDA
HCM
12/19/2022 - 05:11am
Hutchmed initiates Phase II/III trial of fruquintinib with sintilimab
HCM
10/27/2022 - 07:40am
Hutchmed initiates sovleplenib trial
HCM
10/10/2022 - 05:05am
Hutchmed to host conference call
HCM
9/12/2022 - 07:25am
Hutchmed to host conference call
HCM
9/12/2022 - 04:55am
Hutchmed to host conference call
HCM
9/9/2022 - 07:42am
Hutchmed, Inmagene Biopharmaceuticals dose first patient in IMG-004 study
HCM
8/9/2022 - 05:07am
AstraZeneca, Hutchmed report results from SAVANNAH Phase II trial
AZN
,
HCM
8/8/2022 - 06:06am
Hutchmed sees 2022 oncology/immunology revenue $160M-$190M
HCM
8/1/2022 - 07:09am
Hutchmed reports 1H EPS (19c) vs. (14c) last year
HCM
8/1/2022 - 07:07am
dynamic_feed
Breaking News
search
Search
menu
Menu
TheFly.com TheFly.com
